Serum pentosidine levels are associated with reduced eGFR, including in individuals with preserved renal function: a cross-sectional analysis from the Fukuoka Epidemiological Study of Atherosclerosis

BACKGROUND: Advanced glycation end products, particularly pentosidine, are implicated in age-related diseases and are influenced by renal function and glycemic status. Although elevated pentosidine levels are well documented in individuals with chronic kidney disease (CKD) stage G3b or higher, their association with early reductions in estimated glomerular filtration rate (eGFR), including in individuals with preserved renal function, remains incompletely understood. METHODS: We conducted a cross-sectional analysis of 813 Japanese adults from the Fukuoka Epidemiological Study of Atherosclerosis who underwent routine health checkups. Serum pentosidine and Nε-(carboxymethyl)lysine (CML) levels were measured and analyzed in relation to eGFR categories and glycemic markers. RESULTS: Serum pentosidine levels were significantly associated with early reductions in eGFR, even among individuals with values including individuals with preserved renal function (P for trend < 0.01), whereas serum CML levels remained largely unchanged. In multivariable logistic regression analysis, lower eGFR category was significantly associated with elevated serum pentosidine levels (odds ratio, 1.94; 95% confidence interval, 1.40-2.70) after adjustment for covariates. In contrast, no significant association was observed between HbA1c-defined glycemic status and serum pentosidine levels. Triglycerides, high-sensitivity C-reactive protein (hs-CRP), and obesity (body mass index ≥ 25 kg/m²) were inversely associated with serum pentosidine levels. CONCLUSIONS: Lower eGFR, including in individuals with preserved renal function, was associated with higher serum pentosidine levels in this general population. These findings suggest that subtle reductions in renal function, even in individuals with preserved renal function, are associated with higher serum pentosidine levels, which may reflect a combination of cumulative oxidative stress and altered renal handling.

Authors

Institutions

Publication Details

Journal
BMC Nephrology
Published
2026-05-12
DOI
https://doi.org/10.1186/s12882-026-05022-9
Primary Topic
Advanced Glycation End Products research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum pentosidine levels are associated with reduced eGFR, including in individuals with preserved renal function: a cross-sectional analysis from the Fukuoka Epidemiological Study of Atherosclerosis

Kosuke Masutani, Makiko Abe, Atsushi Satoh, Yukiko Shinohara et al.
BMC Nephrology
Advanced Glycation End Products research
article

Serum pentosidine levels are associated with reduced eGFR, including in individuals with preserved renal function: a cross-sectional analysis from the Fukuoka Epidemiological Study of Atherosclerosis

Kosuke Masutani, Makiko Abe, Atsushi Satoh, Yukiko Shinohara, Tetsuhiko Yasuno, Hisatomi Arima, Yori Inoue, Koji Takahashi, Toshiki Maeda, Kazuhiro Tada, Kenji Ito
article en

Abstract

BACKGROUND: Advanced glycation end products, particularly pentosidine, are implicated in age-related diseases and are influenced by renal function and glycemic status. Although elevated pentosidine levels are well documented in individuals with chronic kidney disease (CKD) stage G3b or higher, their association with early reductions in estimated glomerular filtration rate (eGFR), including in individuals with preserved renal function, remains incompletely understood. METHODS: We conducted a cross-sectional analysis of 813 Japanese adults from the Fukuoka Epidemiological Study of Atherosclerosis who underwent routine health checkups. Serum pentosidine and Nε-(carboxymethyl)lysine (CML) levels were measured and analyzed in relation to eGFR categories and glycemic markers. RESULTS: Serum pentosidine levels were significantly associated with early reductions in eGFR, even among individuals with values including individuals with preserved renal function (P for trend < 0.01), whereas serum CML levels remained largely unchanged. In multivariable logistic regression analysis, lower eGFR category was significantly associated with elevated serum pentosidine levels (odds ratio, 1.94; 95% confidence interval, 1.40-2.70) after adjustment for covariates. In contrast, no significant association was observed between HbA1c-defined glycemic status and serum pentosidine levels. Triglycerides, high-sensitivity C-reactive protein (hs-CRP), and obesity (body mass index ≥ 25 kg/m²) were inversely associated with serum pentosidine levels. CONCLUSIONS: Lower eGFR, including in individuals with preserved renal function, was associated with higher serum pentosidine levels in this general population. These findings suggest that subtle reductions in renal function, even in individuals with preserved renal function, are associated with higher serum pentosidine levels, which may reflect a combination of cumulative oxidative stress and altered renal handling.

BMC Nephrology
Kobe Pharmaceutical University (JP), Fukuoka University (JP)
Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 6%
Advanced Glycation End Products research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.